Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 6Glioblastoma 5Childhood Brain Neoplasm 2Neurodegenerative Diseases 1Ischemic Stroke 1Hypoxia 1Hemorrhagic Stroke 1Glioma 1Cranial Nerve Diseases 1Central Nervous System Vascular Malformations 1Central Nervous System Neoplasms 1Central Nervous System Infections 1Brain Injuries 1Adult Brain Glioblastoma 1

Interventions

Temozolomide 1Sodium Chloride 1Saline Solution 1Radiotherapy 1Injections 1Ferrosoferric Oxide 1Dexmedetomidine 13-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypoxia × Ferrosoferric Oxide × CNS × Clear all
NCT02466828 2018-04-18

qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.

Sunnybrook Health Sciences Centre

Phase EARLY_PHASE1 Completed
10 enrolled
CNS

Hypoxia, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡